Is it time to end the Fonterra fund experiment?

Is it time to end the Fonterra fund experiment?
Paul McBeth
Investors in the Fonterra Shareholders’ Fund have had a torrid time over the past decade.After the units were first sold at $5.50 in 2012, they climbed as high as $8.09 in March 2013 before the whey protein concentrate recall later that year took the wind out of Fonterra’s sails.After pottering around between $5 and $6 for several years, they slumped to $3.15 in 2019 during the dairy exporter’s existential crisis when a new management and board rejected the strategy devised by the previous board and chief executive,Theo Spieri...

More Opinion

Microsoft’s shiny new NZ datacentre
Opinion

Peter Griffin: Microsoft’s shiny new NZ datacentre

NZ is a sort of experiment demonstrating the role of high-capacity infrastructure.

Token-ology: the next thing
Opinion

David Chaplin: Token-ology: the next thing

Despite promising developments, fund tokenisation remains in an experimental phase.

David Chaplin 11 Dec 2024
Covid helped polarise us
Opinion

Sir Peter Gluckman: Covid helped polarise us

The pandemic's consequences continue to reverberate. 

Rangatira eyes international stocks
Opinion

Paul McBeth: Rangatira eyes international stocks

The investment firm is finding things tough going for local holdings.

Paul McBeth 10 Dec 2024